G.L. Pharma GmbH, Pharmacare Premium Ltd., Remedica Ltd

Poland

All drugs from this manufacturer

  • SUNITINIB G.L. PHARMA

    The medicinal product is used in adults to treat specific types of cancer: gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and progressive pancreatic neuroendocrine tumors (pNET) that cannot be surgically removed.

    Dosage form: capsules, hard

    Active substance Dosage
    sunitinib 12.5 mg

    ATC: L01EX01

  • SUNITINIB G.L. PHARMA

    The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and progressive pancreatic neuroendocrine tumors (pNET) that cannot be surgically removed.

    Dosage form: capsules, hard

    Active substance Dosage
    sunitinib 25 mg

    ATC: L01EX01

  • SUNITINIB G.L. PHARMA

    The medicinal product is used in adults for the treatment of gastrointestinal stromal tumours (GIST), metastatic renal cell carcinoma (mRCC), and progressive pancreatic neuroendocrine tumours (pNET) that cannot be surgically removed.

    Dosage form: capsules, hard

    Active substance Dosage
    sunitinib 50 mg

    ATC: L01EX01